Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
557
datasets available to search
ShareScore release 0.9.0
Dataset results
557 results for “imatinib”
Randomized Study Comparing the Effect of Dasatinib and Imatinib on Malignant Stem Cells in Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT00852566. IPD Sharing: Not stated. Countries: 3. Publications: 3.
Efficacy and Safety of Imatinib in Scleroderma
ClinicalTrials.gov study NCT00479934. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma
ClinicalTrials.gov study NCT02303899. IPD Sharing: NO. Countries: 1. Publications: 26.
Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia (CML) Patients in Chronic Phase
ClinicalTrials.gov study NCT00327262. IPD Sharing: Not stated. Countries: 1. Publications: 10.
Imatinib Mesylate in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov study NCT00027586. IPD Sharing: Not stated. Countries: 1. Publications: 2.
S0338, Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast Cancer
ClinicalTrials.gov study NCT00087152. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Efficacy and Safety of Generic Imatinib (Carcemia®) Compared to Glivec® in Real-Life Management of Chronic Phase of Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT05282108. IPD Sharing: NO. Countries: 1. Publications: 14.
A Dose-finding Study of a Combination of Imatinib and BKM120 in the Treatment of 3rd Line GIST Patients
ClinicalTrials.gov study NCT01468688. IPD Sharing: NO. Countries: 8. Publications: 1.
Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma
ClinicalTrials.gov study NCT00354523. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ripretinib Combined With Surgery in Advanced GIST That Have Failed Imatinib Therapy: A Multicenter,Observational Study
ClinicalTrials.gov study NCT05354388. IPD Sharing: NO. Countries: 1. Publications: 13.
Imatinib and Toripalimab in Patients With Locally Advanced/Metastatic Melanoma Harbored With CKIT Mut
ClinicalTrials.gov study NCT05274438. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib
ClinicalTrials.gov study NCT05734105. IPD Sharing: Not stated. Countries: 15. Publications: 1.
BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate
ClinicalTrials.gov study NCT00064233. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST
ClinicalTrials.gov study NCT01294202. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Prospective Randomized Phase II Study Evaluating the Monitoring of Imatinib Mesylate Plasmatic Through Level in Patients Newly Diagnosed With CP-CML
ClinicalTrials.gov study NCT02896842. IPD Sharing: NO. Countries: 1. Publications: 0.
Comparison of Imatinib Versus Dasatinib in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid Leukaemia
ClinicalTrials.gov study NCT01460693. IPD Sharing: Not stated. Countries: 1. Publications: 2.
To Compare the Efficacy of Surgery Followed by Sunitinib With Surgery Followed by Imatinib in GIST Patients With Progression on Imatinib.
ClinicalTrials.gov study NCT03424876. IPD Sharing: UNDECIDED. Countries: 1. Publications: 21.
Influence of an Acidic Beverage on the Imatinib Exposure After Major Gastrectomy
ClinicalTrials.gov study NCT02185937. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVE
ClinicalTrials.gov study NCT01491763. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Extension Study of IDEAL (Imatinib) for Chronic Myelgenous Leukemia (CML)
ClinicalTrials.gov study NCT02421926. IPD Sharing: Not stated. Countries: 1. Publications: 10.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.